Skip to main content
Figure 3 | Arthritis Research & Therapy

Figure 3

From: Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year

Figure 3

Distribution of acute phase reactant groups among the CDAI disease activity levels at baseline. Distribution of acute phase reactant groups among the CDAI disease activity levels at baseline in the 4,228 RA patients with a one-year follow-up visit. Percentages within the bars indicate relative proportions of subjects within each CDAI disease activity level. Numbers in parentheses within the bars enumerate subjects in each group. CDAI, Clinical Disease Activity Index; RA, rheumatoid arthritis; LDA, low disease activity; MDA, moderate disease activity; HDA, high disease activity.

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us